WANY
WST icon

Wealthspire Advisors (New York)’s West Pharmaceutical WST Stock Holding History

Wealthspire Advisors (New York)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Buy
+1,248
New +$311K ﹤0.01% 710
2025
Q4 		– Sell
-49
Closed -$12.9K – 2914
2025
Q3 		$12.9K Buy
+49
New +$11.9K ﹤0.01% 1893

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wealthspire Advisors (New York)'s WST Position: Q1 2026 in Review

Wealthspire Advisors (New York) opened a new position in West Pharmaceutical (WST) in Q1 2026: 1,248 shares worth $313K. The stake represents ﹤0.01% of the portfolio and ranks #710 among its holdings. This is a return to the name: Wealthspire Advisors (New York) previously reported a position in WST as recently as Q3 2025.

Wealthspire Advisors (New York) first reported a position in WST in Q3 2025 and has held it in 2 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Wealthspire Advisors (New York) held 1,248 shares of West Pharmaceutical worth $313K as of Q1 2026.
  • West Pharmaceutical was a new Wealthspire Advisors (New York) position in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #710 holding.
  • Wealthspire Advisors (New York) first reported a position in West Pharmaceutical in Q3 2025 and has held it in 2 quarters since.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.